Cholesterol Management
Editor's Choice
Aortic stenosis (AS) is currently the most frequent native valve disease in Europe and is most often seen in elderly patients with co-morbidities.1 Valve replacement is the definitive therapy for...
Drug-eluting stents (DES) have revolutionized the field of interventional cardiology. The US Food and Drug Administration (FDA) is expecting that the total number of DES implanted in 2010 will...
Most recent articles
The Low-density Lipoprotein Cholesterol Cholesterol Verdict - Lower is Better
IntroductionThe debate among cardiologists over whether ‘lower is better’ with regards to serum levels of LDL-C has raged for years. Some...
Reducing Cholesterol to Prevent Coronary Heart Disease
The Framingham Heart Study documented that cholesterol levels correlated with survival.1 The Multiple Risk Factor Intervention Trial2 showed that an...
Optimizing Cardiovascular Outcomes in Patients with Type 2 Diabetes-Clinical Implications of the FIELD Results
Recent statin trials such as the Heart Protection Study (HPS), which included a subgroup of 5,963 diabetic patients,7 and the Collaborative...
Ezetimibe - An Overview of its Low-density Lipoprotein Cholesterol Lowering Efficacy
The need for effective LDL-C-lowering therapy is increasingly important as LDL-C goals become more stringent. The updated National Cholesterol...
Why Many At-Risk Patients Are Not Reaching Their Low-density Lipoprotein Cholesterol Goals and the Need for Alternative Therapies
The results from these trials are in line with the guidelines of several international health organisations that indicate lower LDL-C goals in...
